An in silico model of cytotoxic T-lymphocyte activation in the lymph node following short peptide vaccination
Tumour immunotherapy is dependent upon activation and expansion of tumour targetting immune cells, known as Cytotoxic T-Lymphocytes (CTLs). Cancer vaccines developed in the past have had limited success and the mechanisms resulting in failure are not well characterised. To elucidate these mechani...
Main Authors: | Brown, L, Gaffney, E, Wagg, J, Coles, M |
---|---|
Format: | Journal article |
Published: |
Royal Society
2018
|
Similar Items
-
An in silico model of Cytotoxic T-Lymphocyte activation in the lymph node following short peptide vaccination - data
by: Brown, L
Published: (2017) -
An in silico model of Cytotoxic T-Lymphocyte activation in the lymph node following short peptide vaccination - data (v2)
by: Brown, L
Published: (2018) -
Requirements for T lymphocyte migration in explanted lymph nodes.
by: Huang, J, et al.
Published: (2007) -
Synergy among thymocytes and peripheral lymph node cells in the in vitro generation of lymphocytes cytotoxic to alloantigens.
by: Tigelaar, R, et al.
Published: (1973) -
Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity
by: Backlund, Coralie M, et al.
Published: (2023)